742 related articles for article (PubMed ID: 16157098)
1. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
[TBL] [Abstract][Full Text] [Related]
2. [Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester].
Ye YH; Liu L; Zhan Y; Peng W
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):433-5. PubMed ID: 17083803
[TBL] [Abstract][Full Text] [Related]
3. [Expression and significance of soluble fms-like tyrosine kinase 1 in preeclampsia placenta].
Ye YH; Liu L; Zhan Y; Peng W
Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):521-4. PubMed ID: 17083834
[TBL] [Abstract][Full Text] [Related]
4. Elevated mid-trimester amniotic fluid ADAM-8 concentrations as a potential risk factor for preterm delivery.
Vrachnis N; Malamitsi-Puchner A; Samoli E; Botsis D; Iliodromiti Z; Baka S; Hassiakos D; Creatsas G
J Soc Gynecol Investig; 2006 Apr; 13(3):186-90. PubMed ID: 16638589
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia.
Kupferminc MJ; Peaceman AM; Wigton TR; Rehnberg KA; Socol ML
Am J Obstet Gynecol; 1994 Jun; 170(6):1752-7; discussion 1757-9. PubMed ID: 8203436
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia.
Powers RW; Roberts JM; Cooper KM; Gallaher MJ; Frank MP; Harger GF; Ness RB
Am J Obstet Gynecol; 2005 Jul; 193(1):185-91. PubMed ID: 16021077
[TBL] [Abstract][Full Text] [Related]
7. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
Buhimschi CS; Norwitz ER; Funai E; Richman S; Guller S; Lockwood CJ; Buhimschi IA
Am J Obstet Gynecol; 2005 Mar; 192(3):734-41. PubMed ID: 15746665
[TBL] [Abstract][Full Text] [Related]
8. Second-trimester amniotic fluid or maternal serum interleukin-10 levels and small for gestational age neonates.
Spong CY; Sherer DM; Ghidini A; Jenkins CB; Seydel FD; Eglinton GS
Obstet Gynecol; 1996 Jul; 88(1):24-8. PubMed ID: 8684756
[TBL] [Abstract][Full Text] [Related]
9. [Alteration and potential role of soluble fms-like tyrosine kinase receptor 1 in preeclampsia].
Li Y; Li DH; Yao YQ; Min BH; Zhang CL; Hou XH; Huang L; Zhao HX
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):581-4. PubMed ID: 16202309
[TBL] [Abstract][Full Text] [Related]
10. Amniotic fluid interleukin-18 at mid-trimester genetic amniocentesis: relationship to intraamniotic microbial invasion and preterm delivery.
Daskalakis G; Thomakos N; Papapanagiotou A; Papantoniou N; Mesogitis S; Antsaklis A
BJOG; 2009 Dec; 116(13):1743-8. PubMed ID: 19906019
[TBL] [Abstract][Full Text] [Related]
11. [Predictive value of soluble vascular endothelial growth factor receptor 1 for preeclampsia in second-trimester].
Chen Q; Zhao Y; Zou L; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):161-4. PubMed ID: 17537299
[TBL] [Abstract][Full Text] [Related]
12. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
[TBL] [Abstract][Full Text] [Related]
13. The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia.
Kim YN; Lee DS; Jeong DH; Sung MS; Kim KT
Prenat Diagn; 2009 May; 29(5):464-70. PubMed ID: 19242927
[TBL] [Abstract][Full Text] [Related]
14. Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia.
Papadopoulou E; Sifakis S; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
Growth Horm IGF Res; 2006; 16(5-6):290-6. PubMed ID: 16996762
[TBL] [Abstract][Full Text] [Related]
15. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
[TBL] [Abstract][Full Text] [Related]
16. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop.
McKeeman GC; Ardill JE; Caldwell CM; Hunter AJ; McClure N
Am J Obstet Gynecol; 2004 Oct; 191(4):1240-6. PubMed ID: 15507947
[TBL] [Abstract][Full Text] [Related]
17. Maternal serum placental growth factor and soluble fms-like tyrosine kinase 1 as early predictors of preeclampsia.
Shokry M; Bedaiwy MA; Fathalla MM; Alsemary A; Elwakil S; Murphy A
Acta Obstet Gynecol Scand; 2010; 89(1):143-6. PubMed ID: 20021269
[TBL] [Abstract][Full Text] [Related]
18. Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF.
Krysiak O; Bretschneider A; Zhong E; Webb J; Hopp H; Verlohren S; Fuhr N; Lanowska M; Nonnenmacher A; Vetter R; Jankowski J; Paul M; Schönfelder G
Circ Res; 2005 Dec; 97(12):1253-61. PubMed ID: 16269656
[TBL] [Abstract][Full Text] [Related]
19. Multicenter evaluation of the first automated Elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia.
Schiettecatte J; Russcher H; Anckaert E; Mees M; Leeser B; Tirelli AS; Fiedler GM; Luthe H; Denk B; Smitz J
Clin Biochem; 2010 Jun; 43(9):768-70. PubMed ID: 20206155
[TBL] [Abstract][Full Text] [Related]
20. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia.
Verlohren S; Galindo A; Schlembach D; Zeisler H; Herraiz I; Moertl MG; Pape J; Dudenhausen JW; Denk B; Stepan H
Am J Obstet Gynecol; 2010 Feb; 202(2):161.e1-161.e11. PubMed ID: 19850276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
